VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
RKLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
RKLBRocket Lab USA, Inc.
$82.08$47.5B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRKLBBalance Sheet

Rocket Lab USA, Inc. (RKLB) Balance Sheet

7Y historyFree accessUpdated daily

The balance sheet strengthened dramatically with a $1.4B equity raise, lifting cash to $2.1B and cutting debt to $132M, resulting in a D/E ratio of just 0.04, though retained earnings remain -$1.1B.

RKLB Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets2.9B1.37B692.62M476.72M662.29M774.76M93.11M124.63M
Cash & Short-Term Investments2.3B1.02B418.99M244.77M471.79M690.96M52.79M95.88M
Cash Only2.13B828.66M271.04M162.52M242.51M690.96M52.79M95.88M
Short-Term Investments172.7M187.92M147.95M82.25M229.28M000
Accounts Receivable235.89M122.99M111.53M61.8M47.47M19.01M10.64M8.25M
Days Sales Outstanding77.6774.5993.3292.2282.11111.49110.5162.21
Inventory266.93M158.41M119.07M107.86M92.28M47.9M26.14M14.16M
Days Inventory Outstanding142.49146.52135.79203.78175.42272.65203.06104.44
Other Current Assets20.18M9.84M4.99M14.26M7.63M2.1M914K6.35M
Total Non-Current Assets1.29B958.93M491.72M464.49M326.83M206.08M94.75M70.56M
Property, Plant & Equipment519.99M423.74M262.9M219.8M152.37M93.76M76.73M65.72M
Fixed Asset Turnover1.73x1.42x1.66x1.11x1.38x0.66x0.46x0.74x
Goodwill299.07M205.75M71.02M71.02M71.02M43.31M3.13M0
Intangible Assets320.42M224.75M58.64M68.09M79.69M57.49M11.35M1.33M
Long-Term Investments338.91M82.25M60.69M79.25M9.19M000
Other Non-Current Assets34.12M20.56M35.47M22.83M10.66M5.67M1.14M3.5M
Total Assets4.19B2.32B1.18B941.21M989.12M980.85M187.87M195.19M
Asset Turnover0.27x0.26x0.37x0.26x0.21x0.06x0.19x0.25x
Asset Growth %483.22%96.27%25.83%-4.84%0.84%422.09%-3.75%-
Total Current Liabilities528.2M334.48M339.52M223.37M162.94M96.31M48.42M31.94M
Accounts Payable072.7M53.06M29.3M12.08M3.49M3.37M6.46M
Days Payables Outstanding37.2667.2460.5155.3722.9719.8626.1747.66
Short-Term Debt0012.04M17.76M2.91M2.83M00
Deferred Revenue (Current)645.09M195.44M216.16M139.34M108.34M59.75M26.13M0
Other Current Liabilities528.2M21.24M17.95M15.04M22.25M11M7.77M25.48M
Current Ratio5.48x4.08x2.04x2.13x4.06x8.04x1.92x3.90x
Quick Ratio4.98x3.61x1.69x1.65x3.50x7.55x1.38x3.46x
Cash Conversion Cycle182.9153.87168.61240.64234.56364.28287.4118.99
Total Non-Current Liabilities167.02M268.15M462.36M163.29M152.98M186.09M306.16M26.03M
Long-Term Debt14.85M154.11M389.44M87.59M100.04M97.3M026.02M
Capital Lease Obligations420.02M99.84M66.94M71.34M49.83M28.3M27.3M0
Deferred Tax Liabilities15.75M1.24M891K426K95K466K00
Other Non-Current Liabilities23.19M12.95M5.1M3.94M3M60.03M278.86M1K
Total Liabilities695.22M602.62M801.89M386.67M315.92M282.4M354.58M57.97M
Total Debt133.69M253.96M468.42M176.69M152.78M128.43M27.3M26.02M
Net Debt-2B-574.71M197.38M14.17M-89.73M-562.53M-25.49M-69.85M
Debt / Equity0.04x0.15x1.22x0.32x0.23x0.18x-0.19x
Debt / EBITDA-0.83x-------
Net Debt / EBITDA12.38x-------
Interest Coverage-24.71x-7.53x-46.90x-41.12x-16.05x-19.37x--
Total Equity3.49B1.72B382.45M554.54M673.21M698.45M-166.71M137.22M
Equity Growth %1387.57%350.21%-31.03%-17.63%-3.61%518.96%-221.49%-
Book Value per Share5.553.240.771.151.441.54-0.370.34
Total Shareholders' Equity3.49B1.72B382.45M554.54M673.21M698.45M-166.71M137.22M
Common Stock60K54K50K49K48K45K8K0
Retained Earnings-1.11B-1.01B-813.7M-623.53M-440.95M-305.01M-187.69M-132.69M
Treasury Stock00000000
Accumulated OCI-8.57M-1.96M-2.81M1.54M1.14M1.31M1.05M-79K
Minority Interest00000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Neutron capex and cash burn

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Strengthens on Equity Raise

Total assets surged from $1.2B to $4.2B in 2026Q2, driven by a $1.4B equity raise, while debt fell to $132M, per the latest balance sheet data.

The balance sheet has transformed from a leveraged position with D/E of 1.22 in 2024Q4 to a fortress-like 0.04 in 2026Q2, primarily due to a massive equity infusion. This suggests management is prioritizing financial flexibility to fund Neutron development and potential acquisitions. However, the persistent negative retained earnings of -$1.1B indicate that the equity base is still supported by external capital rather than organic profitability.

Leverage Collapses as Debt Retired

Total debt dropped from $516.6M in 2025Q3 to $132.0M in 2026Q2, with D/E falling from 0.40 to 0.04, as reported in the balance sheet.

The dramatic deleveraging appears to be a strategic move to reduce refinancing risk and interest expense, especially as the company continues to burn cash. With debt now minimal, the balance sheet is well-positioned to weather development delays, but the prior debt levels suggest that the company may have used debt to bridge funding gaps. Investors should monitor whether this low leverage is maintained as Neutron capex intensifies.

Asset Base Expands with Acquisitions

Goodwill jumped from $71.0M to $299.1M in 2026Q2, while PPE grew to $520.0M, reflecting acquisition-driven growth and Neutron infrastructure, per the balance sheet.

The increase in goodwill and intangibles indicates that the company is pursuing a buy-versus-build strategy, particularly in Space Systems. This raises the risk of future impairment if acquired businesses underperform. PPE growth suggests significant investment in launch and manufacturing facilities, which is consistent with the capital-intensive nature of the Neutron program. The asset mix is shifting toward a more asset-heavy model, which may pressure returns in the near term.

Equity Bolstered by Dilutive Raise

Equity surged from $382.5M in 2024Q4 to $3.5B in 2026Q2, but retained earnings remain deeply negative at -$1.1B, as per the balance sheet.

The massive equity increase is primarily from a capital raise, not organic earnings, which dilutes existing shareholders. While this provides a substantial runway, the persistent negative retained earnings highlight that the company has not yet achieved profitability. The reliance on external equity suggests that future dilution may be necessary if cash burn continues, especially given the heavy SBC noted in the cash flow analysis.

Liquidity Buffer Strengthens Significantly

Cash jumped to $2.1B in 2026Q2, with a current ratio of 5.48, up from 2.04 a year earlier, according to the balance sheet.

The liquidity position is now exceptionally strong, providing ample runway for ongoing operating losses and Neutron development. The current ratio of 5.48 indicates a robust ability to cover short-term obligations, which is crucial given the negative operating cash flow. However, the cash balance is likely to be consumed by the accelerating FCF burn, so investors should monitor the burn rate relative to this buffer.

Deferred Revenue Disappears, Raising Questions

Deferred revenue fell from $241.4M in 2026Q1 to $0 in 2026Q2, a sharp decline that may indicate a change in revenue recognition or contract terms, per the balance sheet.

The sudden drop in deferred revenue is non-obvious and warrants investigation. It could suggest that the company is recognizing revenue faster, possibly due to milestone completions, or that contracts are being restructured. This may inflate reported revenue in the short term but could reduce future visibility. Investors should scrutinize the backlog and contract asset trends to assess whether this is a one-time adjustment or a sustainable shift.

RKLB — Frequently Asked Questions

Quick answers to the most common questions about buying RKLB stock.

What are the total assets of Rocket Lab USA, Inc. (RKLB)?

As of 2025, Rocket Lab USA, Inc. (RKLB) had total assets of $2.32B including $1.37B in current assets.

How much debt does Rocket Lab USA, Inc. (RKLB) have?

Rocket Lab USA, Inc. (RKLB) carries total debt of $254.0M, offset by $1.02B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Rocket Lab USA, Inc.?

Rocket Lab USA, Inc. (RKLB) has total shareholders' equity (book value) of $1.72B ($3.24 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Rocket Lab USA, Inc.'s current ratio and liquidity?

Rocket Lab USA, Inc. (RKLB) reported a current ratio of 4.08x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.